Alpelisib
Thông số
1217486-61-7Số CAS
806-598-7Số EC
(2S)-1-N-[4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)-4-pyridinyl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamideTên IUPAC
C19H22F3N5O2SCông thức hóa học
441.5 g/molKhối lượng phân tử
alpelisib; 1217486-61-7; BYL-719; BYL719; Piqray; NVP-BYL719; Vijoice; BYL 719; 08W5N2C97Q; (2S)-1-N-[4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide; 1,2-Pyrrolidinedicarboxamide, N1-(4-methyl-5-(2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl)-2-thiazolyl)-, (2S)-; 1,2-PYRROLIDINEDICARBOXAMIDE, N1-[4-METHYL-5-[2-(2,2,2-TRIFLUORO-1,1-DIMETHYLETHYL)-4-PYRIDINYL]-2-THIAZOLYL]-, (2S)-; DTXSID70153355; (S)-Pyrrolidine-1,2-dicarboxylic acid 2-amide 1-(4-methyl-5-(2-(2,2,2-trifluoro-1,1-dimethylethyl)-pyridin-4-yl)thiazol-2-yl)amide; alpelisibum; (2S)-1-N-(4-methyl-5-(2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl)-1,3-thiazol-2-yl)pyrrolidine-1,2-dicarboxamide; (2S)-1-N-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide; (S)-Pyrrolidine-1,2-dicarboxylic acid 2-amide 1-[4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-pyridin-4-yl]thiazol-2-yl]amide; RefChem:57062; DTXCID7075846; L01XX65; Phosphoinositide 3-kinase Inhibitor BYL719; Alpelisib (BYL719); (S)-N1-(4-Methyl-5-(2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl)thiazol-2-yl)pyrrolidine-1,2-dicarboxamide; UNII-08W5N2C97Q; (2S)-N1-[4-Methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-1,2-pyrrolidinedicarboxamide; Alpelisib [USAN:INN]; MFCD22417085; CHEMBL2396661; (2s)-N~1~-{4-Methyl-5-[2-(1,1,1-Trifluoro-2-Methylpropan-2-Yl)pyridin-4-Yl]-1,3-Thiazol-2-Yl}pyrrolidine-1,2-Dicarboxamide; (S)-N1-(4-methyl-5-(2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl)thiazol-2-yl)pyrrolidine-1,2-dicarboxamide.; Alpelisib [INN]; C19H22F3N5O2S; A lpelisib; 4jps; 1LT; Alpelisib [USAN]; Vijoice (TN); Piqray (TN); ALPELISIB [JAN]; ALPELISIB [MI]; ALPELISIB [WHO-DD]; Alpelisib (JAN/USAN/INN); GTPL7955; orb1226776; orb1307105; SCHEMBL1911869; ALPELISIB [ORANGE BOOK]; SCHEMBL29358059; CHEBI:93752; EX-A405; STUWGJZDJHPWGZ-LBPRGKRZSA-N; BDBM738244; BYL 719; BYL719; GLXC-90284; BDBM50436459; EBC-11472; NSC765974; NSC800065; s2814; AKOS022186315; CCG-269139; CS-0663; DB12015; FP71607; NSC-765974; NSC-800065; SDCCGSBI-0654479.P001; US20250145589, Example Alpelisib; NCGC00346717-03; NCGC00346717-06; NCGC00346717-09; NCGC00346717-12; (2S)-N1-[4-Methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-1,2-pyrrolidine; (2S)-N1-{4-METHYL-5-[2-(1,1,1-TRIFLUORO-2-METHYLPROPAN-2-YL)PYRIDIN-4-YL]-1,3-THIAZOL-2-YL}PYRROLIDINE-1,2-DICARBOXAMIDE; AC-37083; AS-16349; HY-15244; B9700; NS00072895; SW220128-1; cas:1217486-61-7;BYL-719; D11011; EN300-23810842; BRD-K54997624-001-06-0; Q27074391; (2S)-1-N-[4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)-4-pyridinyl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide; (2S)-N1-[4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-4-pyridyl]thiazol-2-yl]pyrrolidine-1,2-dicarboxamide; (2S)-N1-{4-Methyl-5-[1-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide; BYL-719A-1214(S)-N1-(4-METHYL-5-(2-(1,1,1-TRIFLUORO-2-METHYLPROPAN-2-YL)PYRIDIN-4-YL)THIAZOL-2-YL)PYRROLIDINE-1,2-DICARBOXAMIDETên gọi khác
Sản phẩm chứa Alpelisib
피크레이정50밀리그램(알펠리십), 피크레이정150밀리그램(알펠리십), 피크레이정200밀리그램(알펠리십)PIQRAY 50 MG y 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULAPIQRAY 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULAPIQRAY 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULAPIQRAY 50 mg et 200 mg, comprimé pelliculéPIQRAY 200 mg, comprimé pelliculéPIQRAY 150 mg, comprimé pelliculéAlpelisib - Novartis Pharmaceuticals CorporationAlpelisib - ArevipharmaAlpelisibAlpelisibAlpelisib
